Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: A multicentric retrospective study.
Miele E, Anghileri E, Calatozzolo C, Lazzarini E, Patrizi S, Ciolfi A, Pedace L, Patanè M, Abballe L, Paterra R, Maddaloni L, Barresi S, Mastronuzzi A, Petruzzi A, Tramacere I, Farinotti M, Gurrieri L, Pirola E, Scarpelli M, Lombardi G, Villani V, Simonelli M, Merli R, Salmaggi A, Tartaglia M, Silvani A, DiMeco F, Calistri D, Lamperti E, Locatelli F, Indraccolo S, Pollo B. Miele E, et al. Among authors: dimeco f. Cancer Lett. 2024 Apr 28;588:216711. doi: 10.1016/j.canlet.2024.216711. Epub 2024 Feb 27. Cancer Lett. 2024. PMID: 38423245
Local drug delivery in recurrent malignant gliomas.
Boiardi A, Eoli M, Salmaggi A, Lamperti E, Botturi A, Solari A, Di Meco F, Broggi G, Silvani A. Boiardi A, et al. Neurol Sci. 2005 May;26 Suppl 1:S37-9. doi: 10.1007/s10072-005-0403-z. Neurol Sci. 2005. PMID: 15883691 Clinical Trial.
Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma.
Filippini G, Falcone C, Boiardi A, Broggi G, Bruzzone MG, Caldiroli D, Farina R, Farinotti M, Fariselli L, Finocchiaro G, Giombini S, Pollo B, Savoiardo M, Solero CL, Valsecchi MG; Brain Cancer Register of the Fondazione IRCCS (Istituto Ricovero e Cura a Carattere Scientifico) Istituto Neurologico Carlo Besta. Filippini G, et al. Neuro Oncol. 2008 Feb;10(1):79-87. doi: 10.1215/15228517-2007-038. Epub 2007 Nov 9. Neuro Oncol. 2008. PMID: 17993634 Free PMC article.
Cisplatinum and BCNU chemotherapy in primary glioblastoma patients.
Silvani A, Gaviani P, Lamperti EA, Eoli M, Falcone C, Dimeco F, Milanesi IM, Erbetta A, Boiardi A, Fariselli L, Salmaggi A. Silvani A, et al. Among authors: dimeco f. J Neurooncol. 2009 Aug;94(1):57-62. doi: 10.1007/s11060-009-9800-0. Epub 2009 Feb 11. J Neurooncol. 2009. PMID: 19212704 Clinical Trial.
CXCL12, CXCR4 and CXCR7 expression in brain metastases.
Salmaggi A, Maderna E, Calatozzolo C, Gaviani P, Canazza A, Milanesi I, Silvani A, DiMeco F, Carbone A, Pollo B. Salmaggi A, et al. Among authors: dimeco f. Cancer Biol Ther. 2009 Sep;8(17):1608-14. doi: 10.4161/cbt.8.17.9202. Epub 2009 Sep 6. Cancer Biol Ther. 2009. PMID: 19625779
Expression of the new CXCL12 receptor, CXCR7, in gliomas.
Calatozzolo C, Canazza A, Pollo B, Di Pierro E, Ciusani E, Maderna E, Salce E, Sponza V, Frigerio S, Di Meco F, Schinelli S, Salmaggi A. Calatozzolo C, et al. Cancer Biol Ther. 2011 Jan 15;11(2):242-53. doi: 10.4161/cbt.11.2.13951. Epub 2011 Jan 15. Cancer Biol Ther. 2011. PMID: 21084856
236 results